Testing new anticancer drugs before curative locoregional therapies: MDICT 2024 recommendations

Details

Ressource 1Download: 39059061_BIB_8C8AF2A6E0A9.pdf (479.17 [Ko])
State: Public
Version: Final published version
License: CC BY-NC-ND 4.0
Serval ID
serval:BIB_8C8AF2A6E0A9
Type
Article: article from journal or magazin.
Collection
Publications
Institution
UNIL/CHUV
Title
Testing new anticancer drugs before curative locoregional therapies: MDICT 2024 recommendations
Journal
ESMO Open
Author(s)
Stathis A., Le Tourneau C., Tan DSW, Melero I., Garralda E., Peters S., Postel-Vinay S., Yap TA, Martins-Branco D., Nuciforo P., Kholmanskikh O., Eglem S., Seymour LK, Andre F., Britten C., Yap C., Curigliano G., Siu L., Shapiro G., Pentheroudakis G., van Houdt W., Bulbeck H., Mariamidze E., Merino-Vega D.
Working group(s)
Methodology for the Development of Innovative Cancer Therapies Taskforce
ISSN
2059-7029
Publication state
Published
Issued date
08/2024
Volume
9
Number
8
Pages
103649
Language
english
URN
urn:nbn:ch:serval-BIB_8C8AF2A6E0A93
OAI-PMH
oai:serval.unil.ch:BIB_8C8AF2A6E0A9
DOI
10.1016/j.esmoop.2024.103649
Pubmed
39059061
Web of science
001281498200001
Open Access
Yes
Create date
19/08/2024 17:30
Last modification date
21/01/2025 8:23
Usage data